IDH1 and glioma: Because gliomas contain substantial necrotic cell death, and also may be particularly sensitive to DC vaccine immunotherapy [48, 49], they may be especially sensitive to IDH1- or IDH1R132H-mediated modulation of local T cells in the tumor.